For the quarter ending 2025-09-30, RPID had $613K increase in cash & cash equivalents over the period. -$9,124K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Other | - | -17 |
| Net loss | -11,505 | -23,121 |
| Depreciation and amortization expense | 804 | 1,658 |
| Loss on fixed asset impairment | 0 | 19 |
| Non-cash interest expense | 24 | - |
| Stock-based compensation expense | 1,146 | 2,260 |
| Provision for excess and obsolete inventory | 7 | 441 |
| Noncash lease expense | 305 | 609 |
| Loss on revaluation of warrant liability | 41 | - |
| Accretion on investments | -145 | -149 |
| Other | 27 | - |
| Accounts receivable | -618 | -1,471 |
| Inventory | 514 | 1,119 |
| Prepaid expenses and other current assets | -77 | -182 |
| Other long-term assets | 10 | 0 |
| Accounts payable | 251 | 800 |
| Accrued expenses and other current liabilities | 599 | -1,668 |
| Deferred revenue | -1,065 | -463 |
| Other long-term liabilities | 16 | - |
| Net cash used in operating activities | -9,051 | -18,765 |
| Purchases of property and equipment | 73 | 685 |
| Purchases of investments | 20,765 | 2,290 |
| Sale of investments | 2,505 | - |
| Maturity of investments | 8,750 | 23,000 |
| Net cash provided by investing activities | -9,583 | 20,025 |
| Proceeds from issuance of class a common stock - stock option exercise | 62 | 423 |
| Proceeds from issuance of class a common stock - employee stock purchase plan | 72 | 90 |
| Proceeds from issuance of debt | 20,000 | - |
| Payments of debt issuance costs | 878 | - |
| Tax withholding on settlement of restricted stock units | 1 | 418 |
| Payments on finance lease obligations | 8 | 14 |
| Net cash provided by financing activities | 19,247 | 81 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 613 | 1,341 |
| Cash and cash equivalents at beginning of period | 17,276 | - |
| Cash and cash equivalents at end of period | 19,230 | - |
RAPID MICRO BIOSYSTEMS, INC. (RPID)
RAPID MICRO BIOSYSTEMS, INC. (RPID)